Clinical trials
Alcohol Use Disorder clinical trials
Below are recruiting alcohol use disorder clinical trials, each written for real people, not researchers. We’re tracking 370 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06323837RecruitingPhase 2
Testing mirtazapine for methamphetamine use in people on opioid treatment
This trial tests whether the antidepressant mirtazapine can help reduce methamphetamine use in people who are already receiving medication for opioid use disorder. It aims to see if adding this medication improves outcomes for those struggling with both conditions.
Spokane, WashingtonAges 18 years+ - NCT07059078Recruiting
Talk therapy with or without mindfulness for teen drinking
This study tests whether a brief talk therapy session, sometimes combined with mindfulness exercises, can help teens reduce alcohol use. It is designed for teens who get care at Johns Hopkins and already drink alcohol at least once a month.
Baltimore, MarylandAges 12–17 - NCT07713251Recruiting
Computer skills training for teens seeking alcohol help
This study tests a computer-based program called Path180 to help teenagers ages 13-19 reduce their alcohol use. If you are already seeing a counselor or in treatment for alcohol or mental health, this program might add extra support.
Providence, Rhode IslandAges 13–19 - NCT05800899Recruiting
Brief counseling program for alcohol-related injuries in Latinxs
This trial tests a culturally tailored, short counseling session for people who are Latinx and have alcohol-related injuries. It aims to reduce health disparities by helping improve treatment access and outcomes after an injury.
El Paso, TexasAges 18 years+ - NCT06585709Recruiting
Brain stimulation for opioid use disorder treatment
This trial tests if brain stimulation can help people starting buprenorphine for opioid use disorder. It aims to improve treatment outcomes and support recovery.
Durham, North CarolinaAges 18 years+ - NCT07027839RecruitingPhase 1
Alcohol effects on brain imaging for phosphodiesterase
This study uses PET scans to see how alcohol affects a protein in the brain called PDE4B. It may help explain how alcohol works in the body.
Bethesda, MarylandAges 21–70 - NCT07079826Recruiting
Sparrow Link device for opioid withdrawal in hospital
This trial tests a device placed on the ear to help manage opioid withdrawal symptoms in hospitalized adults. It's for people still having withdrawal despite standard medications or those who've chosen not to take methadone or buprenorphine.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT06838468Enrolling by invitation
Study on liver health in alcohol detox patients
This study is looking at liver health in people staying in a detox unit for alcohol use disorder. Researchers want to see how common liver problems are in this group. Participating involves extra tests like blood work, an ultrasound, and a special liver scan (FibroScan).
Sabadell, BarcelonaAges 18–75 - NCT06994962Recruiting
Smartphone app to reduce heavy drinking in young adults
This study tests a smartphone app designed to help young adults (ages 18–25) drink less alcohol. If you're a heavy drinker and want to use technology to cut back, this app might be a good fit for you.
Boston, MassachusettsAges 18–25 - NCT06005298Recruiting
Testing SBIRT to help with PrEP and alcohol use
This study looks at whether talking about alcohol use can help people stick with their PrEP routine. It tests a simple program called SBIRT (Screening, Brief Intervention, and Referral to Treatment) to support your health and HIV prevention.
Louisville, KentuckyAges 18–85 - NCT07654205Recruiting
Smartphone intervention for young adults with ADHD and heavy drinking
This study tests a smartphone-based intervention for young adults with ADHD who also drink heavily. It aims to help manage both conditions together. You may qualify if you are 18-25, have ADHD (combined type), drink heavily on a weekly basis, own a smartphone, and can read English.
Pittsburgh, PennsylvaniaAges 18–25 - NCT06349083RecruitingPhase 2
Psilocybin-assisted treatment for alcohol use disorder
This study tests whether psilocybin, a psychedelic drug, combined with therapy can help people reduce or stop drinking. It aims to understand how psilocybin affects the brain and behavior in people with alcohol use disorder.
New York, New YorkAges 18–65 - NCT07724275Recruiting
Digital recovery support for Black adults in Detroit
This study tests a digital program to help Black adults in early recovery from alcohol problems stay on track. You'd receive weekly text surveys and complete two in-person visits over 13 weeks.
Detroit, MichiganAges 18 years+ - NCT04084860RecruitingPhase 2
Brief medicine trial to help reduce heavy alcohol drinking
This Phase 2 study tests a brief medication approach meant to reduce “problem drinking.” It may help people cut back or stop alcohol use by adjusting brain signaling related to drinking cravings and urges.
New York, New YorkAges 21–70 - NCT05062369Recruiting
Brain stimulation plus training to support alcohol abstinence
This study tests whether a combination of brain stimulation (tDCS) and cognitive training can help people with alcohol use disorder stay abstinent. You may be included if you are currently not drinking and can commit to the program timeline.
Minneapolis, MinnesotaAges 18–65 - NCT06139224Recruiting
Gut Bacteria and Inflammation in HIV and Heavy Drinking
This study looks at how gut bacteria and inflammation interact in people with both HIV and heavy alcohol use. It aims to find new ways to improve health by understanding these connections.
Chicago, IllinoisAges 45–75 - NCT06211959Recruiting
Planning to avoid alcohol: a training study for alcohol use disorder
This study tests whether adding a simple planning technique (called 'implementation intentions') to a computer-based training program helps people with alcohol use disorder change their habits. The training teaches you to avoid alcohol-related cues, and the planning step may make it more effective.
LilleAges Any age - NCT06244641Recruiting
New Model for Relapse in Alcohol Use Disorder
This study is testing a new way to understand and predict relapse in people with alcohol use disorder. If you're currently hospitalized for this condition, researchers want to learn from your experience to improve care.
Brussels, Brussels CapitalAges 18 years+ - NCT06283472Recruiting
Boosting positive thinking in early recovery
This trial tests a program to help people in early recovery from heavy drinking improve their ability to think positively about the future. It may help you stay motivated and build healthier habits.
Indianapolis, IndianaAges 18–60 - NCT06302413Recruiting
Thinking about the future during early recovery
This study looks at how thinking about the future might help people in early recovery from substance use. It recruits people who have been abstinent for 2 weeks to 1 year and are in outpatient treatment.
Indianapolis, IndianaAges 18–60 - NCT06303778Recruiting
App and medication study to reduce heavy drinking
This study tests if using a smartphone app along with medication can help Veterans reduce heavy drinking. You will be randomly assigned to one of two groups to see which approach works better.
Phoenix, ArizonaAges 18–80 - NCT06319872RecruitingPhase 1
Study of disulfiram for vision in retinal degeneration
This trial tests whether disulfiram, a drug used for alcohol use disorder, can improve vision in people with retinal degeneration. You must have an alcohol use diagnosis and agree to avoid alcohol for 6 months.
Rochester, New YorkAges 18 years+ - NCT06489782Recruiting
New approach to test alcohol use disorder medications
This study tests a new way to quickly screen medications for alcohol use disorder (AUD). You will have lab sessions where your drinking is monitored to see how different medicines affect your alcohol use.
New Haven, ConnecticutAges 21–65 - NCT06496191Recruiting
Fecal transplant for alcohol use in cirrhotics
This trial tests whether a fecal microbiota transplant (FMT) can help people with alcohol-related cirrhosis who are still drinking. It aims to see if FMT can reduce alcohol cravings and improve liver health.
New Delhi, National Capital Territory of DelhiAges 18–70
Hear when a new Alcohol Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for alcohol use disorder?
- Yes. Clin2 currently lists 370 recruiting alcohol use disorder studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a alcohol use disorder trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a alcohol use disorder trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.